Stephane Van Rooijen's Location

France

Stephane Van Rooijen's Work

Stephane Van Rooijen's Education

  • KU Leuven

    Doctor of Medicine (M.D.)

  • Erasmus University Rotterdam

    Master of Business Administration (MBA)

  • Georgetown University - The McDonough School of Business

    MBA - exchange

Stephane Van Rooijen's Skills

  • Customer Service
  • Business Analysis
  • Healthcare
  • Accounting
  • Drug Development
  • Airline Management
  • Enterprise Software
  • Analytics
  • Investments
  • Commodity Markets

Stephane Van Rooijen's Summary

Stephane van Rooijen, based in France, is currently a Chief Executive Officer at Flamingo Therapeutics, bringing experience from previous roles at Dynacure, Confo Therapeutics and ViroPharma Incorporated - acquired by Shire in 2014. Stephane van Rooijen holds a Doctor of Medicine (M.D.) @ KU Leuven. With a robust skill set that includes Customer Service, Business Analysis, Healthcare, Accounting, Drug Development and more, Stephane van Rooijen contributes valuable insights to the industry. Stephane van Rooijen has 5 emails on RocketReach.
Arrow

5 free lookups per month.
No credit card required.

If you need more lookups, subscriptions start at $48 USD/month.

Redirecting you to the search page.

If you're not automatically redirected, please click here

Not the Stephane Van Rooijen you were looking for?

Find contact details for 700 million professionals.

People Like Stephane van Rooijen

Top Flamingo Therapeutics Employees

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users